Home / Inspections / 1028621

FDA Inspection 1028621 — Jan Bolinder, MD

Jan Bolinder, MD — FEI 3010600232

The FDA completed an inspection of Jan Bolinder, MD on September 22, 2017 in Stockholm. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 22, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Stockholm (Sweden)

Additional Details

Clinical Investigator (CI)

Facility

FDA data resources